Skip to main content
SpringerLink
Log in

Influence of vasospasm on visual function

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

In a number of patients with etiologically unexplained visual field loss, a vasospastic syndrome could be found with the help of a capillaroscopic local cooling test on the fingers. In the patients with proven vasospastic syndrome, the visual field defects were increased after a cold water test and decreased after a therapy with calcium entry blockers. General aspects of the physiology and pathophysiology of the circulation and especially of the circulation in the eye are presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shepherd, JT, Vanhoutte, PM. The human cardiovascular system; Facts and concepts. New York: Raven Press, 1979.

    Google Scholar 

  2. Vanhoutte, PM, Leusen, I. Mechanisms of vasodilatation. Basel: Karger, 1978.

    Google Scholar 

  3. Sparks, HV, Phair, RD. In Vanhoutte, PM, Leusen, I, eds. Mechanisms of vasodilatation. Basel: Karger, 1978.

    Google Scholar 

  4. Johansson, B. Process involved in vascular smooth muscle contraction and relaxation. Circ Res 1978; 34 (suppl I): 1–14.

    Google Scholar 

  5. Somlyo, AP, Somlyo, AV. Vascular smooth muscle. I. Normal structure, pathology, biochemistry and biophysics. Pharmacol Rev 1968; 20: 197.

    Google Scholar 

  6. Somlyo, AP, Somlyo, AV. Vascular smooth muscle. II. Pharmacology of normal and hypertensive vessels. Pharmacol Rev 1970; 22: 197.

    Google Scholar 

  7. Hayreh, SS. The ophthalmic artery. III. Branches. Br J Ophthalmol 1962; 46: 212.

    Google Scholar 

  8. Hayreh, SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 1977; 95: 1553.

    Google Scholar 

  9. Hayreh, SS. Pathogenesis of optic nerve damage and visual field defects. In: Heilman, LK, Richardson, KT, eds. Glaucoma. Stuttgart: Thieme Verlag, 1978.

    Google Scholar 

  10. Bettman, J, Fellows, VA. Technique for the determination of blood volume changes in the choroid and retina by the use of radioactive phosphorus. Am J Ophthalmol 1954; 38: 513.

    Google Scholar 

  11. Bill, A. Calorimetric procedures for the study of the blood flow through the ciliary region and the choroid in rabbits. Acta Ophthalmol 1962; 40: 1.

    Google Scholar 

  12. Niesei, P. Messungen von experimentell erzeugten Änderungen der Aderhautdurch-blutung bei Kaninchen. Basel: Karger, 1962.

    Google Scholar 

  13. Rodenhaeuser, JH. Uveadurchblutung und Augeninnendruck. Stuttgart: Enke, 1962.

    Google Scholar 

  14. Schulte, AVM. Retinal Fluorotachometry. Thesis. Rotterdam: Erasmus University, 1986.

    Google Scholar 

  15. Gloster, J. Fundus oxymetry. Exp Eye Res 1967; 6: 187.

    Google Scholar 

  16. Kogure, K. Infrared absorption angiography of the fundus circulation. Arch Ophthalmol 1970; 83: 209.

    Google Scholar 

  17. Bill, A, Nilsson, SPE. Control of ocular blood flow. J Cardiovasc Pharmacol 1985; 7 (suppl 3): 96–102.

    Google Scholar 

  18. Bill, A. Some aspects of the ocular circulation. Invest Ophthalmol 1985; 26: 410–424.

    Google Scholar 

  19. Bill, A, Sperber, G, Ujiie, K. Physiology of the choroidal vascular bed. Int Ophthalmol 1983; 6: 101.

    Google Scholar 

  20. Bollinger, A. Nicht degenerative Arteriopathien. Klinik und Therapie der vasospastischen Syndrome. In:von Kappert A, ed. Aktuelle Probleme der Angiologie, Band 17. Bern: Huber, 1972; 154–169.

    Google Scholar 

  21. Bollinger, A. Funktionelle Angiologie. Stuttgart: Thieme, 1979.

    Google Scholar 

  22. Luethi, R, Muench, U, Kistler, HJ. Vasospastisches Syndrom bei junger Frau mit Migraene, Raynaud-Syndrom, Hirninfarkt und Herzinfarkt. Schweiz Med Wschr 1984; 114: 1465–1469.

    Google Scholar 

  23. Proudfit, W. Types of spasm and their diagnosis. Am J Cardiol 1978; 44: 841–842.

    Google Scholar 

  24. Coffman, JD, Cohen, RA. Vasospasm —ubiquitous? N Engl J Med 1984; 304: 780–782.

    Google Scholar 

  25. Miller, D, Waters, DD, Warnica, W, Szlachcic, J, Kraeft, J, Theroux, P. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981; 304: 763–766.

    Google Scholar 

  26. Zahavi, I, Chagnac, A, Hering, R, Davidovich, S, Kuritzky, A. Prevalence of Raynaud's phenomenon in patients with migraine. Arch Intern Med 1984; 144: 742–744.

    Google Scholar 

  27. Robertson, D, Oates, JA. Variant angina and Raynaud's phenomenon. Lancet 1978; I: 452.

    Google Scholar 

  28. Engel, HJ, Lichtlen, P. Angina pectoris and myocardial infarction with normal coronary arteries. PRAXIS 1980; 69: 1618–1627.

    Google Scholar 

  29. Maseri, A, L'Abbate, A, Baroldi, G et al. Coronary Vasospasmus; a possible cause of myocardial infarction. A conclusion derived from the study of “preinfarction” angina. N Engl J Med 1978; 299: 1271–1277.

    Google Scholar 

  30. Hellstrom, HR. Evidence in favor of the vasospastic cause of coronary artery thrombosis. Am Heart J 1979; 97: 449–452.

    Google Scholar 

  31. Vincent, GM, Anderson, JG, Marshall, HU. Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 1983; 309: 220–223.

    Google Scholar 

  32. Adams, RD. Headache. In: Isselbacher, KJ, Adams, RD, Braunwald, E, Petersdorf, RG, Wilson, JD, eds. Harrison's principles of internal medicine, 9th ed. New York: McGraw-Hill, 1980; 18–27.

    Google Scholar 

  33. Leon-Sotomayor, LA. Cardiac migraine. Reports of 12 cases. Angiology 1974; 25: 161–171.

    Google Scholar 

  34. Editorial. Coronary artery spasm. Brit Med J 1979; I: 969–970.

  35. Gould, L, Reddy, CVR, Brooklyn, FACA. Coronary artery spasm. Angiology 1980; 31: 365–374.

    Google Scholar 

  36. Hillis, LD, Braunwald, E. Coronary artery spasm. N Engl J Med 1978; 299: 695–702.

    Google Scholar 

  37. El-Maraghi, NRH, Sealey, BJ. Recurrent myocardial infarction in a young man due to coronary artery spasm demonstrated at autopsy. Circulation 1980; 61: 199–207.

    Google Scholar 

  38. Johnson, AD, Detwiler, JH. Coronary spasm, variant angina and recurrent myocardial infarctions. Circulation 1977; 55: 947–950.

    Google Scholar 

  39. Lewey, RI, Smith, JB, Silver, MJ, Saia, J, Walinsky, P, Wiener, L. Detection of thromboxane B2 in the peripheral blood of patients with Prinzmetal's angina. Prostaglandins Med 1979; 2: 243–248.

    Google Scholar 

  40. Yasue, H, Touyania, M, Kato, H, Tanaka, S, Akiyama, F. Prinzmetal's variant form of angina as a manifestation of alpha-adrenergic receptor-mediated coronary artery spasm: Documentation by coronary arteriography. Am Heart J 1976; 91: 148–155.

    Google Scholar 

  41. Ricci, DR, Orlick, AE, Cipriano, PR, Guthaner, DF, Harrison, DC. Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol 1979; 43: 1073–1079.

    Google Scholar 

  42. Edmeads, J. Cerebral blood flow in migraine. Headache 1977; 17: 148–152.

    Google Scholar 

  43. Solomon, GD. Calcium channel blockers in migraine. Lancet 1982; 2: 162.

    Google Scholar 

  44. Skinhoy, E. Hemodynamic studies within the brain during migraine. Arch Neurol 1973; 29: 95–98.

    Google Scholar 

  45. Mathew, NT, Hrastnik, F, Meyer, JS. Regional cerebral blood flow in the diagnosis of headache. Headache 1976; 15: 252–260.

    Google Scholar 

  46. Altmann, E, Schmidt, PKH, Wolff, L, Jochem, G. Die dißerential-diagnostische Abgrenzung von organischen und funktionellen Durchblutungsstörungen im akralen Bereich. Dtsch GesundhWesen 1970; 34: 2178–2181.

    Google Scholar 

  47. Thiele, P. Bedeutung und Symptopmatik funktioneller und organischer Durchblutungs-störungen und kutaner Mikroangiopathien. Z Ges Inn Med 1983; 6: 172–175.

    Google Scholar 

  48. Emanuel, MB. Specific calcium antagonists in the treatment of peripheral vascular disease. Angiology 1979; 30: 454–469.

    Google Scholar 

  49. Hess, H. Zur Pathogenese der arteriellen Durchblutungsstörungen. Dtsch Med J 1972; 23: 340–342.

    Google Scholar 

  50. Pola, P, Savi, L, Serrichio, M, Dal, Lago A, Grilli, M, Tondi, P. Use of physiological substance, acetyl-carnitine, in the treatment of angiospastic syndromes. Drugs Exp Clin Res 1984; 10: 213–218.

    Google Scholar 

  51. Appenzeller, O, Davison, K, Marshall, J. Reflex vasomotor abnormalities in the hands of migrainous subjects. J Neurol Neurosurg Psychiat 1963; 26: 447–450.

    Google Scholar 

  52. Meier, B, Mahler, F, Bollinger, A. Blood flow speed in nailfold capillaries in healthy subjects and patients with vasospastic and organic acral blood flow disorders. VASA 1978; 7: 194–198.

    Google Scholar 

  53. Mahler, F, Saner, H, Marth, D, Ursenbacher, B. Local cold exposure test for examination of the nailfold capillary circulation in Raynaud's syndrome. Int Angiology 1983; 4: 137–142.

    Google Scholar 

  54. Coffman, JD, Cohen, AS. Total and capillar fingertip blood flow in Raynaud's phenomenon. N Engl J Med 1971; 285: 259–263.

    Google Scholar 

  55. Kontos, HA, Wassermann, AJ. Effect of reserpine in Raynaud's phenomenon. Circulation 1969; 39: 259–266.

    Google Scholar 

  56. Johnston, ENM, Summerly, B, Birnstingl, M. Prognosis in Raynaud's phenomenon after sympathectomy. Br Med J 1965; 1: 962–964.

    Google Scholar 

  57. Coffman, JD, Davies, WT. Vasospastic disease: A review. Prog Cardiovasc Dis 1975; 18: 123–146.

    Google Scholar 

  58. Thune, P, Fyrando, O. Further observation on the therapy with a betastimulating agent in Raynaud's phenomenon. Acta Chir Scand (suppl) 1976; 465: 84–86.

    Google Scholar 

  59. Weiner, N. Drugs that inhibit adrenergic nerves and block adrenergic receptors. In: Gilman, AG, Goodman, LS, Gilman, A, eds. The pharmacological basis of therapeutics, 6th ed. New York: Macmillan, 1980; 176–210.

    Google Scholar 

  60. Heupler, FA. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriogrammes. Am J Cardiol 1980; 45: 873–881.

    Google Scholar 

  61. Bollinger, A, Butti, P. Primäres und sekundäres Raynaud-Syndrom. Schweiz Med Wschr 1976; 106: 415–421.

    Google Scholar 

  62. Runge, E, Thiele, P. Klinik und Differentialdiagnose der primären akralen Durchblutungs-störungen. Z Ges Inn Med 1983; 6: 175–178.

    Google Scholar 

  63. Mahler, F, Bollinger, A. Die Kapillarmikroskopie als Untersuchungsmethode in der klinischen Angiologie. Dtsch Med Wschr 1978; 103: 523.

    Google Scholar 

  64. Bollinger, A, Butti, P, Barras, JP, Trachsler, H, Siegenthaler, W. Red blood cell velocity in nailfold capillaries of man, measured by a television microscopy technique. Microvasc Res 1974; 7: 61.

    Google Scholar 

  65. Butti, P, Intaglietta, M, Reimann, H, Hollinger, Ch, Bollinger, A, Anliker, M. Capillary red blood cell velocity measurements in human nailfold by videodensitometry methods. Microvasc Res 1975; 10: 220.

    Google Scholar 

  66. Mahler, F, Meier, B, Frey, R, Bollinger, A, Anliker, M. Reaction of red blood cell velocity in nailfold capillaries to local cold in patients with vasospastic disease. Bibl Anat (Basel) 1977; 16: 155–158.

    Google Scholar 

  67. Bollinger, A, Mahler, F, Meier, B. Velocity patterns in nailfold capillaries of normal subjects and patients with Raynaud's disease and acrocyanosis. Bibl Anat (Basel) 1977; 16: 142.

    Google Scholar 

  68. Parks, VJ, Sandison, AG, Skinner, SL et al. The mechanism of the vasodilatator action of reserpine in man. Clin Sci 1961; 20: 289.

    Google Scholar 

  69. LeRoy, EC, Downey, JA, Cannon, PJ. Skin capillary blood flow in scleroderma. J Clin Invest 1971; 50: 930.

    Google Scholar 

  70. Varadi, DP, Lawrence, AM. Suppression of Raynaud's phenomenon by methyldopa. Arch Int Med 1969; 124: 13.

    Google Scholar 

  71. Kahan, A, Weber, S, Amor, B, Guerin, F, Degeorges, M. Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon. N Engl J Med 1983; 18: 1102–1103.

    Google Scholar 

  72. Schick, EC, Liang, CS, Heupler, FA et al. Randomized placebo-controlled study of nifedipine in patients with vasospastic angina (abstr.). Am J Cardiol 1982; 49: 929.

    Google Scholar 

  73. Smith, CD, McKendry, RJR. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet 1982; 2: 1299–1301.

    Google Scholar 

  74. Rodeheffer, RJ, Rommer, JA, Wigley, F, Smith, CR. Controlled doubleblind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 1983; 15: 880–883.

    Google Scholar 

  75. Solomon, GD, Steel, JG, Spaccavento, LJ. Verapamil prophylaxis of migraine. J Amer Med Ass 1983; 250: 2500–2504.

    Google Scholar 

  76. Pierce, EH, Delia Valle, R, Wielenga, J. Raynaud's disease and nifedipine. Ann Intern Med 1983; 97: 111.

    Google Scholar 

  77. Louis, PA. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache 1981; 21: 235–239.

    Google Scholar 

  78. Paolo, P, Savi, L. Peripheral vascular dynamics studied by calcium ion inhibition. Angiology 1978; 29: 506–519.

    Google Scholar 

  79. Solomon, GD. Calcium channel blockers in migraine. Lancet 1982; 2: 162.

    Google Scholar 

  80. Shug, AL et al. Changes in tissue levels of carnitine and other metabolites during myocardial schemia and anoxia. Arch Biochem 1978; 25: 187.

    Google Scholar 

  81. Bohmer, T, Bergrem, H, Eiklid, K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; I: 126.

    Google Scholar 

  82. Engel, AP, Angelini, C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 1973; 179: 899.

    Google Scholar 

  83. 83. Gasser, P, Flammer, J, Guthauser, U, Niesei, P. Bedeutung des vasospastischen Syndroms in der Augenheilkunde. Klin Mbl Augenheilk 1986; 188: 398–399.

    Google Scholar 

  84. Flammer J, Jenni A, Bebie H, Keller B. The Octopus Glaucoma Program Gl. Glaucoma (in press).

Download references

Author information

Authors and Affiliations

  1. University Eye Clinic, CH-3010, Bern, Switzerland

    Paul Gasser &  Josef Flammer

Authors
  1. Paul Gasser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Josef Flammer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported by the Swiss National Fund Nr. 3'790—0.84.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gasser, P., Flammer, J. Influence of vasospasm on visual function. Doc Ophthalmol 66, 3–18 (1987). https://doi.org/10.1007/BF00144735

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00144735

Keywords

Search

Navigation